FFCP PHASE1:Hg19::chr6:18497083..18497107,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C224 | |||
|description=CAGE_peak_at_chr6:18497083..18497107,+ | |||
|id=chr6:18497083..18497107,+ | |||
|ontology_enrichment_celltype=CL:0002149!6.14e-14!6;CL:0002255!6.14e-14!6;CL:0002603!1.33e-12!3;CL:0000313!2.16e-10!1 | |||
|ontology_enrichment_celltype_v019=CL:0000313;2.70e-40;1!CL:0000159;6.30e-21;2!CL:0002149;6.34e-08;6!CL:0002255;6.34e-08;6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000313,2.21e-40,1;CL:0000159,5.70e-21,2;CL:0002149,6.34e-08,6;CL:0002255,6.34e-08,6 | |||
|ontology_enrichment_development_v019=UBERON:0006242;2.70e-40;1 | |||
|ontology_enrichment_disease=DOID:4468!3.13e-19!2;DOID:299!8.73e-17!25;DOID:120!1.69e-15!27;DOID:193!2.23e-14!29;DOID:3001!6.14e-14!6;DOID:2152!2.16e-10!1 | |||
|ontology_enrichment_disease_v019=DOID:4468;1.05e-79;2!DOID:2152;2.70e-40;1!DOID:299;5.94e-26;25!DOID:120;4.28e-24;27!DOID:193;1.72e-22;29!DOID:3001;6.34e-08;6 | |||
|ontology_enrichment_disease_v019_2=DOID:4468,1.05e-79,2;DOID:2152,2.21e-40,1;DOID:299,5.75e-26,25;DOID:120,4.16e-24,27;DOID:193,1.67e-22,29;DOID:3001,6.34e-08,6 | |||
|ontology_enrichment_uberon=UBERON:0003134!7.15e-11!37;UBERON:0000474!7.15e-11!37;UBERON:0004911!2.16e-10!1;UBERON:0000995!2.88e-10!21;UBERON:0006834!6.33e-10!1;UBERON:0005795!8.56e-10!22;UBERON:0003975!8.56e-10!22;UBERON:0003100!9.74e-10!41;UBERON:0002363!1.17e-09!1;UBERON:0007647!1.17e-09!1;UBERON:0010115!1.17e-09!1;UBERON:0004175!1.34e-08!25;UBERON:0003133!3.31e-08!48;UBERON:0004733!4.94e-07!12;UBERON:0002028!4.94e-07!12;UBERON:0007277!4.94e-07!12;UBERON:0002037!9.97e-07!6;UBERON:0006215!9.97e-07!6 | |||
|ontology_enrichment_uberon_v019=UBERON:0004911;2.70e-40;1!UBERON:0004909;6.30e-21;2!UBERON:0002110;1.96e-14;3!UBERON:0002294;6.21e-07;7!UBERON:0001173;6.21e-07;7 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004911,2.21e-40,1;UBERON:0004909,5.70e-21,2;UBERON:0002110,2.09e-14,3;UBERON:0006242,2.09e-14,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.123121058076788,0,0.313454721478088,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.207970861530807,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.511707249066704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105551628892876,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243713489631284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0941438007767792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.111308705022906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.31900115973192,0,0,0,0,0,0,0,0,0,0,14.5588664524339,65.2931232636591,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063186579628488,0,0,0,0,0,0,9.10750547295337,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.13452994739353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110929051536852,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.310525913752519,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0887023701626388,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.22910686854405,0.93061915699296,0,2.79638579494481,0,0.243835849964539,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122241444182866,0,0,0,0 | |||
|short_description=p@chr6:18497083..18497107,+ | |||
}} |
Revision as of 10:21, 22 January 2014
Short description: | p@chr6:18497083..18497107, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr6:18497083..18497107, + |
Coexpression cluster: | C224_clear_serous_pleomorphic_choriocarcinoma_mesothelioma_amniotic_renal |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
serous secreting cell | 2.21e-40 | 1 |
seromucus secreting cell | 5.70e-21 | 2 |
epithelial cell of uterus | 6.34e-08 | 6 |
stromal cell of endometrium | 6.34e-08 | 6 |
Ontology term | p-value | n |
---|---|---|
epithelium of female gonad | 2.21e-40 | 1 |
epithelium of gonad | 5.70e-21 | 2 |
gallbladder | 2.09e-14 | 3 |
gall bladder primordium | 2.09e-14 | 3 |
Ontology term | p-value | n |
---|---|---|
clear cell adenocarcinoma | 1.05e-79 | 2 |
ovary epithelial cancer | 2.21e-40 | 1 |
adenocarcinoma | 5.75e-26 | 25 |
female reproductive organ cancer | 4.16e-24 | 27 |
reproductive organ cancer | 1.67e-22 | 29 |
female reproductive endometrioid cancer | 6.34e-08 | 6 |